nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—ADRA1B—Amitriptyline—migraine	0.146	0.259	CbGbCtD
Dextroamphetamine—SLC6A2—Amitriptyline—migraine	0.134	0.236	CbGbCtD
Dextroamphetamine—ADRA1A—Amitriptyline—migraine	0.116	0.204	CbGbCtD
Dextroamphetamine—CYP2D6—Timolol—migraine	0.052	0.0919	CbGbCtD
Dextroamphetamine—CYP2D6—Propranolol—migraine	0.0463	0.0819	CbGbCtD
Dextroamphetamine—CYP2D6—Amitriptyline—migraine	0.0401	0.0708	CbGbCtD
Dextroamphetamine—CYP2D6—Verapamil—migraine	0.0318	0.0562	CbGbCtD
Dextroamphetamine—SLC6A2—locus ceruleus—migraine	0.0092	0.137	CbGeAlD
Dextroamphetamine—TAAR1—neck—migraine	0.00745	0.111	CbGeAlD
Dextroamphetamine—SLC6A2—sympathetic nervous system—migraine	0.00728	0.109	CbGeAlD
Dextroamphetamine—SLC6A2—autonomic nervous system—migraine	0.00489	0.073	CbGeAlD
Dextroamphetamine—Phenacemide—SCN1A—migraine	0.00346	0.58	CrCbGaD
Dextroamphetamine—SLC6A3—nerve—migraine	0.00341	0.0509	CbGeAlD
Dextroamphetamine—TAAR1—nervous system—migraine	0.00298	0.0445	CbGeAlD
Dextroamphetamine—TAAR1—central nervous system—migraine	0.00287	0.0429	CbGeAlD
Dextroamphetamine—SLC6A2—nerve—migraine	0.00275	0.0411	CbGeAlD
Dextroamphetamine—SLC18A2—brainstem—migraine	0.00194	0.0289	CbGeAlD
Dextroamphetamine—SLC6A3—brainstem—migraine	0.00146	0.0218	CbGeAlD
Dextroamphetamine—SLC6A2—brainstem—migraine	0.00118	0.0176	CbGeAlD
Dextroamphetamine—ADRA1A—brainstem—migraine	0.0011	0.0164	CbGeAlD
Dextroamphetamine—ADRA1B—head—migraine	0.00108	0.0161	CbGeAlD
Dextroamphetamine—SLC18A2—head—migraine	0.00107	0.016	CbGeAlD
Dextroamphetamine—ADRA1B—nervous system—migraine	0.00102	0.0153	CbGeAlD
Dextroamphetamine—SLC18A2—nervous system—migraine	0.00101	0.0151	CbGeAlD
Dextroamphetamine—ADRA1B—central nervous system—migraine	0.000986	0.0147	CbGeAlD
Dextroamphetamine—SLC18A2—central nervous system—migraine	0.000976	0.0146	CbGeAlD
Dextroamphetamine—SLC18A2—cerebellum—migraine	0.000954	0.0142	CbGeAlD
Dextroamphetamine—ADRA1A—cardiovascular system—migraine	0.000896	0.0134	CbGeAlD
Dextroamphetamine—Insomnia—Amitriptyline—migraine	0.000818	0.00377	CcSEcCtD
Dextroamphetamine—SLC6A3—head—migraine	0.000809	0.0121	CbGeAlD
Dextroamphetamine—Euphoric mood—Topiramate—migraine	0.000806	0.00372	CcSEcCtD
Dextroamphetamine—Somnolence—Amitriptyline—migraine	0.000804	0.00371	CcSEcCtD
Dextroamphetamine—Disturbance in sexual arousal—Gabapentin—migraine	0.000803	0.00371	CcSEcCtD
Dextroamphetamine—Affect lability—Gabapentin—migraine	0.000797	0.00368	CcSEcCtD
Dextroamphetamine—Dyspepsia—Amitriptyline—migraine	0.000796	0.00367	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Timolol—migraine	0.000794	0.00366	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Gabapentin—migraine	0.000791	0.00365	CcSEcCtD
Dextroamphetamine—Decreased appetite—Amitriptyline—migraine	0.000786	0.00363	CcSEcCtD
Dextroamphetamine—ADRA1B—brain—migraine	0.000783	0.0117	CbGeAlD
Dextroamphetamine—Convulsion—Propranolol—migraine	0.000782	0.00361	CcSEcCtD
Dextroamphetamine—Fatigue—Amitriptyline—migraine	0.000779	0.0036	CcSEcCtD
Dextroamphetamine—Tremor—Verapamil—migraine	0.000777	0.00359	CcSEcCtD
Dextroamphetamine—SLC18A2—brain—migraine	0.000775	0.0116	CbGeAlD
Dextroamphetamine—Constipation—Amitriptyline—migraine	0.000773	0.00357	CcSEcCtD
Dextroamphetamine—Irritability—Gabapentin—migraine	0.000773	0.00357	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Valproic Acid—migraine	0.000771	0.00356	CcSEcCtD
Dextroamphetamine—Mood swings—Gabapentin—migraine	0.000767	0.00354	CcSEcCtD
Dextroamphetamine—SLC6A3—nervous system—migraine	0.000767	0.0114	CbGeAlD
Dextroamphetamine—Weight decreased—Valproic Acid—migraine	0.000764	0.00352	CcSEcCtD
Dextroamphetamine—Agitation—Verapamil—migraine	0.000763	0.00352	CcSEcCtD
Dextroamphetamine—Angioedema—Verapamil—migraine	0.000758	0.0035	CcSEcCtD
Dextroamphetamine—Depression—Valproic Acid—migraine	0.000751	0.00346	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Valproic Acid—migraine	0.000746	0.00344	CcSEcCtD
Dextroamphetamine—SLC6A3—central nervous system—migraine	0.000738	0.011	CbGeAlD
Dextroamphetamine—Anaphylactic shock—Propranolol—migraine	0.000736	0.0034	CcSEcCtD
Dextroamphetamine—Libido decreased—Topiramate—migraine	0.000735	0.00339	CcSEcCtD
Dextroamphetamine—Palpitations—Verapamil—migraine	0.000733	0.00338	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Valproic Acid—migraine	0.000732	0.00338	CcSEcCtD
Dextroamphetamine—Infection—Propranolol—migraine	0.000731	0.00337	CcSEcCtD
Dextroamphetamine—Sweating—Valproic Acid—migraine	0.000722	0.00333	CcSEcCtD
Dextroamphetamine—SLC6A3—cerebellum—migraine	0.000722	0.0108	CbGeAlD
Dextroamphetamine—Convulsion—Verapamil—migraine	0.000719	0.00332	CcSEcCtD
Dextroamphetamine—Urticaria—Amitriptyline—migraine	0.000718	0.00331	CcSEcCtD
Dextroamphetamine—Hypertension—Verapamil—migraine	0.000716	0.00331	CcSEcCtD
Dextroamphetamine—Body temperature increased—Amitriptyline—migraine	0.000715	0.0033	CcSEcCtD
Dextroamphetamine—Chest pain—Verapamil—migraine	0.000706	0.00326	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Timolol—migraine	0.000692	0.00319	CcSEcCtD
Dextroamphetamine—Dry mouth—Verapamil—migraine	0.000691	0.00319	CcSEcCtD
Dextroamphetamine—Weight decreased—Timolol—migraine	0.00068	0.00314	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Verapamil—migraine	0.000677	0.00312	CcSEcCtD
Dextroamphetamine—Disturbance in sexual arousal—Topiramate—migraine	0.000676	0.00312	CcSEcCtD
Dextroamphetamine—Infection—Verapamil—migraine	0.000673	0.0031	CcSEcCtD
Dextroamphetamine—Affect lability—Topiramate—migraine	0.000671	0.00309	CcSEcCtD
Dextroamphetamine—Depression—Timolol—migraine	0.000668	0.00308	CcSEcCtD
Dextroamphetamine—Insomnia—Propranolol—migraine	0.000666	0.00307	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Topiramate—migraine	0.000665	0.00307	CcSEcCtD
Dextroamphetamine—Tachycardia—Verapamil—migraine	0.000661	0.00305	CcSEcCtD
Dextroamphetamine—Dyspnoea—Propranolol—migraine	0.000656	0.00303	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Verapamil—migraine	0.000655	0.00302	CcSEcCtD
Dextroamphetamine—Somnolence—Propranolol—migraine	0.000654	0.00302	CcSEcCtD
Dextroamphetamine—SLC6A2—head—migraine	0.000653	0.00974	CbGeAlD
Dextroamphetamine—Irritability—Topiramate—migraine	0.00065	0.003	CcSEcCtD
Dextroamphetamine—Asthenia—Amitriptyline—migraine	0.000649	0.00299	CcSEcCtD
Dextroamphetamine—Dyspepsia—Propranolol—migraine	0.000648	0.00299	CcSEcCtD
Dextroamphetamine—CYP2D6—brainstem—migraine	0.000647	0.00965	CbGeAlD
Dextroamphetamine—Mood swings—Topiramate—migraine	0.000645	0.00298	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Gabapentin—migraine	0.000645	0.00297	CcSEcCtD
Dextroamphetamine—Sweating—Timolol—migraine	0.000642	0.00296	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—TNF—migraine	0.00064	0.107	CrCbGaD
Dextroamphetamine—Decreased appetite—Propranolol—migraine	0.00064	0.00295	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Valproic Acid—migraine	0.000639	0.00295	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Gabapentin—migraine	0.000639	0.00295	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Propranolol—migraine	0.000636	0.00293	CcSEcCtD
Dextroamphetamine—Fatigue—Propranolol—migraine	0.000635	0.00293	CcSEcCtD
Dextroamphetamine—Weight decreased—Gabapentin—migraine	0.000633	0.00292	CcSEcCtD
Dextroamphetamine—Constipation—Propranolol—migraine	0.00063	0.0029	CcSEcCtD
Dextroamphetamine—Depression—Gabapentin—migraine	0.000622	0.00287	CcSEcCtD
Dextroamphetamine—Abdominal pain upper—Topiramate—migraine	0.000622	0.00287	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Gabapentin—migraine	0.000619	0.00285	CcSEcCtD
Dextroamphetamine—SLC6A2—nervous system—migraine	0.000619	0.00923	CbGeAlD
Dextroamphetamine—Diarrhoea—Amitriptyline—migraine	0.000619	0.00285	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Gabapentin—migraine	0.000615	0.00284	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Topiramate—migraine	0.000614	0.00283	CcSEcCtD
Dextroamphetamine—Insomnia—Verapamil—migraine	0.000612	0.00283	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Gabapentin—migraine	0.000612	0.00282	CcSEcCtD
Dextroamphetamine—ADRA1A—head—migraine	0.000607	0.00905	CbGeAlD
Dextroamphetamine—Urinary tract infection—Gabapentin—migraine	0.000607	0.0028	CcSEcCtD
Dextroamphetamine—Dyspnoea—Verapamil—migraine	0.000604	0.00279	CcSEcCtD
Dextroamphetamine—Somnolence—Verapamil—migraine	0.000602	0.00278	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Propranolol—migraine	0.000602	0.00278	CcSEcCtD
Dextroamphetamine—Sweating—Gabapentin—migraine	0.000598	0.00276	CcSEcCtD
Dextroamphetamine—Dizziness—Amitriptyline—migraine	0.000598	0.00276	CcSEcCtD
Dextroamphetamine—Dyspepsia—Verapamil—migraine	0.000596	0.00275	CcSEcCtD
Dextroamphetamine—SLC6A2—central nervous system—migraine	0.000596	0.00889	CbGeAlD
Dextroamphetamine—SLC6A3—brain—migraine	0.000586	0.00875	CbGeAlD
Dextroamphetamine—Urticaria—Propranolol—migraine	0.000585	0.0027	CcSEcCtD
Dextroamphetamine—Fatigue—Verapamil—migraine	0.000584	0.00269	CcSEcCtD
Dextroamphetamine—Body temperature increased—Propranolol—migraine	0.000582	0.00269	CcSEcCtD
Dextroamphetamine—Abdominal pain—Propranolol—migraine	0.000582	0.00269	CcSEcCtD
Dextroamphetamine—Constipation—Verapamil—migraine	0.000579	0.00267	CcSEcCtD
Dextroamphetamine—Tension—Valproic Acid—migraine	0.000577	0.00266	CcSEcCtD
Dextroamphetamine—ADRA1A—nervous system—migraine	0.000575	0.00858	CbGeAlD
Dextroamphetamine—Vomiting—Amitriptyline—migraine	0.000575	0.00265	CcSEcCtD
Dextroamphetamine—Nervousness—Valproic Acid—migraine	0.000571	0.00264	CcSEcCtD
Dextroamphetamine—Rash—Amitriptyline—migraine	0.00057	0.00263	CcSEcCtD
Dextroamphetamine—Dermatitis—Amitriptyline—migraine	0.00057	0.00263	CcSEcCtD
Dextroamphetamine—Headache—Amitriptyline—migraine	0.000566	0.00261	CcSEcCtD
Dextroamphetamine—ADRA1A—central nervous system—migraine	0.000554	0.00827	CbGeAlD
Dextroamphetamine—Tremor—Valproic Acid—migraine	0.000551	0.00254	CcSEcCtD
Dextroamphetamine—Phentermine—SLC6A4—migraine	0.000544	0.0911	CrCbGaD
Dextroamphetamine—Hypersensitivity—Propranolol—migraine	0.000542	0.0025	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Topiramate—migraine	0.000542	0.0025	CcSEcCtD
Dextroamphetamine—ADRA1A—cerebellum—migraine	0.000541	0.00808	CbGeAlD
Dextroamphetamine—Agitation—Valproic Acid—migraine	0.000541	0.00249	CcSEcCtD
Dextroamphetamine—Urticaria—Verapamil—migraine	0.000538	0.00248	CcSEcCtD
Dextroamphetamine—Angioedema—Valproic Acid—migraine	0.000538	0.00248	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Topiramate—migraine	0.000538	0.00248	CcSEcCtD
Dextroamphetamine—Nausea—Amitriptyline—migraine	0.000537	0.00248	CcSEcCtD
Dextroamphetamine—Weight decreased—Topiramate—migraine	0.000533	0.00246	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Gabapentin—migraine	0.00053	0.00244	CcSEcCtD
Dextroamphetamine—Asthenia—Propranolol—migraine	0.000528	0.00244	CcSEcCtD
Dextroamphetamine—Depression—Topiramate—migraine	0.000524	0.00242	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Topiramate—migraine	0.000521	0.0024	CcSEcCtD
Dextroamphetamine—Palpitations—Valproic Acid—migraine	0.00052	0.0024	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—HTR1A—migraine	0.000518	0.00358	CbGpPWpGaD
Dextroamphetamine—Pseudoephedrine—SLC6A4—migraine	0.000515	0.0864	CrCbGaD
Dextroamphetamine—Tension—Timolol—migraine	0.000514	0.00237	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Topiramate—migraine	0.00051	0.00235	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—TAC1—migraine	0.00051	0.00353	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—NPS—migraine	0.00051	0.00353	CbGpPWpGaD
Dextroamphetamine—Nervousness—Timolol—migraine	0.000509	0.00235	CcSEcCtD
Dextroamphetamine—Hypertension—Valproic Acid—migraine	0.000508	0.00234	CcSEcCtD
Dextroamphetamine—SLC6A3—Transmission across Chemical Synapses—CACNA1A—migraine	0.000505	0.0035	CbGpPWpGaD
Dextroamphetamine—Diarrhoea—Propranolol—migraine	0.000504	0.00232	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR1D—migraine	0.000502	0.00347	CbGpPWpGaD
Dextroamphetamine—Chest pain—Valproic Acid—migraine	0.000501	0.00231	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—HTR2C—migraine	0.0005	0.00346	CbGpPWpGaD
Dextroamphetamine—Anxiety—Valproic Acid—migraine	0.000499	0.0023	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Verapamil—migraine	0.000499	0.0023	CcSEcCtD
Dextroamphetamine—ADRA1A—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000495	0.00342	CbGpPWpGaD
Dextroamphetamine—Dry mouth—Valproic Acid—migraine	0.00049	0.00226	CcSEcCtD
Dextroamphetamine—Dizziness—Propranolol—migraine	0.000487	0.00225	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—EDNRA—migraine	0.000486	0.00337	CbGpPWpGaD
Dextroamphetamine—Asthenia—Verapamil—migraine	0.000486	0.00224	CcSEcCtD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000483	0.00334	CbGpPWpGaD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000483	0.00334	CbGpPWpGaD
Dextroamphetamine—Anaphylactic shock—Valproic Acid—migraine	0.00048	0.00222	CcSEcCtD
Dextroamphetamine—Tension—Gabapentin—migraine	0.000479	0.00221	CcSEcCtD
Dextroamphetamine—Angioedema—Timolol—migraine	0.000479	0.00221	CcSEcCtD
Dextroamphetamine—Infection—Valproic Acid—migraine	0.000477	0.0022	CcSEcCtD
Dextroamphetamine—Nervousness—Gabapentin—migraine	0.000474	0.00219	CcSEcCtD
Dextroamphetamine—SLC6A2—brain—migraine	0.000473	0.00706	CbGeAlD
Dextroamphetamine—Tachycardia—Valproic Acid—migraine	0.000469	0.00216	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR ligand binding—CALCA—migraine	0.000468	0.00324	CbGpPWpGaD
Dextroamphetamine—Vomiting—Propranolol—migraine	0.000468	0.00216	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR2B—migraine	0.000466	0.00323	CbGpPWpGaD
Dextroamphetamine—Hyperhidrosis—Valproic Acid—migraine	0.000464	0.00214	CcSEcCtD
Dextroamphetamine—Rash—Propranolol—migraine	0.000464	0.00214	CcSEcCtD
Dextroamphetamine—Dermatitis—Propranolol—migraine	0.000464	0.00214	CcSEcCtD
Dextroamphetamine—Diarrhoea—Verapamil—migraine	0.000463	0.00214	CcSEcCtD
Dextroamphetamine—Palpitations—Timolol—migraine	0.000463	0.00214	CcSEcCtD
Dextroamphetamine—ADRA1A—Amine ligand-binding receptors—HTR2A—migraine	0.00046	0.00318	CbGpPWpGaD
Dextroamphetamine—Anorexia—Valproic Acid—migraine	0.000458	0.00211	CcSEcCtD
Dextroamphetamine—Tremor—Gabapentin—migraine	0.000457	0.00211	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR1D—migraine	0.000456	0.00315	CbGpPWpGaD
Dextroamphetamine—Hypertension—Timolol—migraine	0.000452	0.00209	CcSEcCtD
Dextroamphetamine—Agitation—Gabapentin—migraine	0.000448	0.00207	CcSEcCtD
Dextroamphetamine—Dizziness—Verapamil—migraine	0.000448	0.00207	CcSEcCtD
Dextroamphetamine—Chest pain—Timolol—migraine	0.000446	0.00206	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Topiramate—migraine	0.000446	0.00206	CcSEcCtD
Dextroamphetamine—Angioedema—Gabapentin—migraine	0.000446	0.00206	CcSEcCtD
Dextroamphetamine—Anxiety—Timolol—migraine	0.000444	0.00205	CcSEcCtD
Dextroamphetamine—ADRA1A—brain—migraine	0.00044	0.00656	CbGeAlD
Dextroamphetamine—TAAR1—GPCR ligand binding—HTR7—migraine	0.000438	0.00303	CbGpPWpGaD
Dextroamphetamine—Nausea—Propranolol—migraine	0.000437	0.00202	CcSEcCtD
Dextroamphetamine—Dry mouth—Timolol—migraine	0.000436	0.00201	CcSEcCtD
Dextroamphetamine—Insomnia—Valproic Acid—migraine	0.000434	0.002	CcSEcCtD
Dextroamphetamine—Palpitations—Gabapentin—migraine	0.000431	0.00199	CcSEcCtD
Dextroamphetamine—Vomiting—Verapamil—migraine	0.000431	0.00199	CcSEcCtD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—TRPM8—migraine	0.000429	0.00297	CbGpPWpGaD
Dextroamphetamine—Dyspnoea—Valproic Acid—migraine	0.000428	0.00198	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Timolol—migraine	0.000427	0.00197	CcSEcCtD
Dextroamphetamine—Rash—Verapamil—migraine	0.000427	0.00197	CcSEcCtD
Dextroamphetamine—Somnolence—Valproic Acid—migraine	0.000427	0.00197	CcSEcCtD
Dextroamphetamine—Dermatitis—Verapamil—migraine	0.000427	0.00197	CcSEcCtD
Dextroamphetamine—Infection—Timolol—migraine	0.000425	0.00196	CcSEcCtD
Dextroamphetamine—Headache—Verapamil—migraine	0.000424	0.00196	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR2B—migraine	0.000423	0.00293	CbGpPWpGaD
Dextroamphetamine—Dyspepsia—Valproic Acid—migraine	0.000423	0.00195	CcSEcCtD
Dextroamphetamine—Convulsion—Gabapentin—migraine	0.000423	0.00195	CcSEcCtD
Dextroamphetamine—Hypertension—Gabapentin—migraine	0.000421	0.00194	CcSEcCtD
Dextroamphetamine—Amphetamine—SLC6A4—migraine	0.000418	0.0701	CrCbGaD
Dextroamphetamine—Decreased appetite—Valproic Acid—migraine	0.000417	0.00193	CcSEcCtD
Dextroamphetamine—Chest pain—Gabapentin—migraine	0.000415	0.00192	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Valproic Acid—migraine	0.000415	0.00191	CcSEcCtD
Dextroamphetamine—Fatigue—Valproic Acid—migraine	0.000414	0.00191	CcSEcCtD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—HTR2B—migraine	0.000414	0.00286	CbGpPWpGaD
Dextroamphetamine—Anxiety—Gabapentin—migraine	0.000414	0.00191	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Timolol—migraine	0.000413	0.00191	CcSEcCtD
Dextroamphetamine—SLC18A2—Transmembrane transport of small molecules—HTR3A—migraine	0.000411	0.00284	CbGpPWpGaD
Dextroamphetamine—Constipation—Valproic Acid—migraine	0.000411	0.00189	CcSEcCtD
Dextroamphetamine—Anorexia—Timolol—migraine	0.000407	0.00188	CcSEcCtD
Dextroamphetamine—Dry mouth—Gabapentin—migraine	0.000406	0.00187	CcSEcCtD
Dextroamphetamine—TAAR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000403	0.00279	CbGpPWpGaD
Dextroamphetamine—Tension—Topiramate—migraine	0.000403	0.00186	CcSEcCtD
Dextroamphetamine—Nausea—Verapamil—migraine	0.000402	0.00186	CcSEcCtD
Dextroamphetamine—Nervousness—Topiramate—migraine	0.000399	0.00184	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Gabapentin—migraine	0.000398	0.00184	CcSEcCtD
Dextroamphetamine—SLC6A2—NRF2 pathway—SLC6A4—migraine	0.000396	0.00274	CbGpPWpGaD
Dextroamphetamine—Infection—Gabapentin—migraine	0.000395	0.00182	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Valproic Acid—migraine	0.000393	0.00181	CcSEcCtD
Dextroamphetamine—Tachycardia—Gabapentin—migraine	0.000388	0.00179	CcSEcCtD
Dextroamphetamine—Methamphetamine—SLC6A4—migraine	0.000387	0.0649	CrCbGaD
Dextroamphetamine—SLC6A3—Neuronal System—CACNA1A—migraine	0.000387	0.00268	CbGpPWpGaD
Dextroamphetamine—Insomnia—Timolol—migraine	0.000387	0.00178	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Gabapentin—migraine	0.000385	0.00178	CcSEcCtD
Dextroamphetamine—Tremor—Topiramate—migraine	0.000384	0.00177	CcSEcCtD
Dextroamphetamine—Urticaria—Valproic Acid—migraine	0.000381	0.00176	CcSEcCtD
Dextroamphetamine—Dyspnoea—Timolol—migraine	0.000381	0.00176	CcSEcCtD
Dextroamphetamine—Somnolence—Timolol—migraine	0.00038	0.00175	CcSEcCtD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—TRPM8—migraine	0.00038	0.00263	CbGpPWpGaD
Dextroamphetamine—Body temperature increased—Valproic Acid—migraine	0.00038	0.00175	CcSEcCtD
Dextroamphetamine—Abdominal pain—Valproic Acid—migraine	0.00038	0.00175	CcSEcCtD
Dextroamphetamine—Anorexia—Gabapentin—migraine	0.000379	0.00175	CcSEcCtD
Dextroamphetamine—Agitation—Topiramate—migraine	0.000377	0.00174	CcSEcCtD
Dextroamphetamine—Dyspepsia—Timolol—migraine	0.000376	0.00174	CcSEcCtD
Dextroamphetamine—Decreased appetite—Timolol—migraine	0.000372	0.00171	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—CALCRL—migraine	0.00037	0.00256	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—RAMP1—migraine	0.00037	0.00256	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.00037	0.00256	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal disorder—Timolol—migraine	0.000369	0.0017	CcSEcCtD
Dextroamphetamine—Fatigue—Timolol—migraine	0.000369	0.0017	CcSEcCtD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—HTR2B—migraine	0.000368	0.00254	CbGpPWpGaD
Dextroamphetamine—Palpitations—Topiramate—migraine	0.000363	0.00167	CcSEcCtD
Dextroamphetamine—Insomnia—Gabapentin—migraine	0.00036	0.00166	CcSEcCtD
Dextroamphetamine—CYP2D6—head—migraine	0.000357	0.00533	CbGeAlD
Dextroamphetamine—Convulsion—Topiramate—migraine	0.000356	0.00164	CcSEcCtD
Dextroamphetamine—Dyspnoea—Gabapentin—migraine	0.000355	0.00164	CcSEcCtD
Dextroamphetamine—Hypertension—Topiramate—migraine	0.000354	0.00163	CcSEcCtD
Dextroamphetamine—Somnolence—Gabapentin—migraine	0.000354	0.00163	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Valproic Acid—migraine	0.000354	0.00163	CcSEcCtD
Dextroamphetamine—SLC6A2—Monoamine Transport—TNF—migraine	0.000352	0.00244	CbGpPWpGaD
Dextroamphetamine—SLC6A3—NRF2 pathway—SLC6A4—migraine	0.000351	0.00243	CbGpPWpGaD
Dextroamphetamine—Dyspepsia—Gabapentin—migraine	0.00035	0.00162	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Timolol—migraine	0.00035	0.00161	CcSEcCtD
Dextroamphetamine—Chest pain—Topiramate—migraine	0.000349	0.00161	CcSEcCtD
Dextroamphetamine—Anxiety—Topiramate—migraine	0.000348	0.00161	CcSEcCtD
Dextroamphetamine—Decreased appetite—Gabapentin—migraine	0.000346	0.0016	CcSEcCtD
Dextroamphetamine—Asthenia—Valproic Acid—migraine	0.000344	0.00159	CcSEcCtD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000344	0.00238	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal disorder—Gabapentin—migraine	0.000344	0.00159	CcSEcCtD
Dextroamphetamine—Fatigue—Gabapentin—migraine	0.000343	0.00158	CcSEcCtD
Dextroamphetamine—Dry mouth—Topiramate—migraine	0.000342	0.00158	CcSEcCtD
Dextroamphetamine—Constipation—Gabapentin—migraine	0.00034	0.00157	CcSEcCtD
Dextroamphetamine—Urticaria—Timolol—migraine	0.00034	0.00157	CcSEcCtD
Dextroamphetamine—CYP2D6—nervous system—migraine	0.000339	0.00506	CbGeAlD
Dextroamphetamine—Body temperature increased—Timolol—migraine	0.000338	0.00156	CcSEcCtD
Dextroamphetamine—Abdominal pain—Timolol—migraine	0.000338	0.00156	CcSEcCtD
Dextroamphetamine—Infection—Topiramate—migraine	0.000333	0.00154	CcSEcCtD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000329	0.00228	CbGpPWpGaD
Dextroamphetamine—Diarrhoea—Valproic Acid—migraine	0.000329	0.00152	CcSEcCtD
Dextroamphetamine—Tachycardia—Topiramate—migraine	0.000327	0.00151	CcSEcCtD
Dextroamphetamine—CYP2D6—central nervous system—migraine	0.000326	0.00487	CbGeAlD
Dextroamphetamine—Gastrointestinal pain—Gabapentin—migraine	0.000325	0.0015	CcSEcCtD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000325	0.00225	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000325	0.00225	CbGpPWpGaD
Dextroamphetamine—Hyperhidrosis—Topiramate—migraine	0.000324	0.00149	CcSEcCtD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00032	0.00221	CbGpPWpGaD
Dextroamphetamine—Anorexia—Topiramate—migraine	0.000319	0.00147	CcSEcCtD
Dextroamphetamine—CYP2D6—cerebellum—migraine	0.000319	0.00476	CbGeAlD
Dextroamphetamine—Dizziness—Valproic Acid—migraine	0.000318	0.00146	CcSEcCtD
Dextroamphetamine—Urticaria—Gabapentin—migraine	0.000316	0.00146	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Timolol—migraine	0.000315	0.00145	CcSEcCtD
Dextroamphetamine—Body temperature increased—Gabapentin—migraine	0.000315	0.00145	CcSEcCtD
Dextroamphetamine—Abdominal pain—Gabapentin—migraine	0.000315	0.00145	CcSEcCtD
Dextroamphetamine—SLC6A3—Monoamine Transport—TNF—migraine	0.000312	0.00216	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—RAMP1—migraine	0.000309	0.00214	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CALCRL—migraine	0.000309	0.00214	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR ligand binding—HTR2A—migraine	0.000307	0.00212	CbGpPWpGaD
Dextroamphetamine—Asthenia—Timolol—migraine	0.000307	0.00141	CcSEcCtD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000306	0.00212	CbGpPWpGaD
Dextroamphetamine—Vomiting—Valproic Acid—migraine	0.000305	0.00141	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR1B—migraine	0.000304	0.0021	CbGpPWpGaD
Dextroamphetamine—Insomnia—Topiramate—migraine	0.000303	0.0014	CcSEcCtD
Dextroamphetamine—Rash—Valproic Acid—migraine	0.000303	0.0014	CcSEcCtD
Dextroamphetamine—Dermatitis—Valproic Acid—migraine	0.000302	0.0014	CcSEcCtD
Dextroamphetamine—Headache—Valproic Acid—migraine	0.000301	0.00139	CcSEcCtD
Dextroamphetamine—SLC6A2—NRF2 pathway—TGFBR2—migraine	0.000299	0.00207	CbGpPWpGaD
Dextroamphetamine—Dyspnoea—Topiramate—migraine	0.000299	0.00138	CcSEcCtD
Dextroamphetamine—Somnolence—Topiramate—migraine	0.000298	0.00137	CcSEcCtD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000295	0.00204	CbGpPWpGaD
Dextroamphetamine—Dyspepsia—Topiramate—migraine	0.000295	0.00136	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Gabapentin—migraine	0.000293	0.00135	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR1A—migraine	0.000293	0.00202	CbGpPWpGaD
Dextroamphetamine—Diarrhoea—Timolol—migraine	0.000292	0.00135	CcSEcCtD
Dextroamphetamine—Decreased appetite—Topiramate—migraine	0.000291	0.00134	CcSEcCtD
Dextroamphetamine—ADRA1B—LPA receptor mediated events—FOS—migraine	0.00029	0.00201	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal disorder—Topiramate—migraine	0.000289	0.00133	CcSEcCtD
Dextroamphetamine—Fatigue—Topiramate—migraine	0.000289	0.00133	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—TAC1—migraine	0.000288	0.00199	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—NPS—migraine	0.000288	0.00199	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—ATP1A2—migraine	0.000288	0.00199	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—ATP1A3—migraine	0.000288	0.00199	CbGpPWpGaD
Dextroamphetamine—Constipation—Topiramate—migraine	0.000286	0.00132	CcSEcCtD
Dextroamphetamine—Asthenia—Gabapentin—migraine	0.000286	0.00132	CcSEcCtD
Dextroamphetamine—Nausea—Valproic Acid—migraine	0.000285	0.00132	CcSEcCtD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000284	0.00197	CbGpPWpGaD
Dextroamphetamine—Dizziness—Timolol—migraine	0.000283	0.0013	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR2C—migraine	0.000283	0.00196	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—HTR3A—migraine	0.000276	0.00191	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR1B—migraine	0.000276	0.00191	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—EDNRA—migraine	0.000275	0.0019	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—RAMP1—migraine	0.000274	0.0019	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CALCRL—migraine	0.000274	0.0019	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000274	0.0019	CbGpPWpGaD
Dextroamphetamine—Gastrointestinal pain—Topiramate—migraine	0.000274	0.00126	CcSEcCtD
Dextroamphetamine—Diarrhoea—Gabapentin—migraine	0.000272	0.00126	CcSEcCtD
Dextroamphetamine—Vomiting—Timolol—migraine	0.000272	0.00125	CcSEcCtD
Dextroamphetamine—Rash—Timolol—migraine	0.00027	0.00124	CcSEcCtD
Dextroamphetamine—Dermatitis—Timolol—migraine	0.000269	0.00124	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR1D—migraine	0.000269	0.00186	CbGpPWpGaD
Dextroamphetamine—Headache—Timolol—migraine	0.000268	0.00124	CcSEcCtD
Dextroamphetamine—Urticaria—Topiramate—migraine	0.000266	0.00123	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR1A—migraine	0.000266	0.00184	CbGpPWpGaD
Dextroamphetamine—Body temperature increased—Topiramate—migraine	0.000265	0.00122	CcSEcCtD
Dextroamphetamine—Abdominal pain—Topiramate—migraine	0.000265	0.00122	CcSEcCtD
Dextroamphetamine—SLC6A3—NRF2 pathway—TGFBR2—migraine	0.000265	0.00183	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—CALCA—migraine	0.000265	0.00183	CbGpPWpGaD
Dextroamphetamine—Dizziness—Gabapentin—migraine	0.000263	0.00121	CcSEcCtD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000262	0.00181	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—TAC1—migraine	0.000262	0.00181	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—NPS—migraine	0.000262	0.00181	CbGpPWpGaD
Dextroamphetamine—CYP2D6—brain—migraine	0.000259	0.00386	CbGeAlD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR2C—migraine	0.000257	0.00178	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—NPS—migraine	0.000256	0.00177	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—TAC1—migraine	0.000256	0.00177	CbGpPWpGaD
Dextroamphetamine—Nausea—Timolol—migraine	0.000254	0.00117	CcSEcCtD
Dextroamphetamine—Vomiting—Gabapentin—migraine	0.000253	0.00117	CcSEcCtD
Dextroamphetamine—Rash—Gabapentin—migraine	0.000251	0.00116	CcSEcCtD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—HTR2C—migraine	0.000251	0.00174	CbGpPWpGaD
Dextroamphetamine—Dermatitis—Gabapentin—migraine	0.000251	0.00116	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR2B—migraine	0.00025	0.00173	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—EDNRA—migraine	0.00025	0.00173	CbGpPWpGaD
Dextroamphetamine—Headache—Gabapentin—migraine	0.000249	0.00115	CcSEcCtD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR7—migraine	0.000247	0.00171	CbGpPWpGaD
Dextroamphetamine—Hypersensitivity—Topiramate—migraine	0.000247	0.00114	CcSEcCtD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—HTR3A—migraine	0.000245	0.00169	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—EDNRA—migraine	0.000244	0.00169	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000243	0.00169	CbGpPWpGaD
Dextroamphetamine—Asthenia—Topiramate—migraine	0.00024	0.00111	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling by GPCR—CALCA—migraine	0.00024	0.00166	CbGpPWpGaD
Dextroamphetamine—Nausea—Gabapentin—migraine	0.000236	0.00109	CcSEcCtD
Dextroamphetamine—Diarrhoea—Topiramate—migraine	0.000229	0.00106	CcSEcCtD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000229	0.00158	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000229	0.00158	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—TAC1—migraine	0.000227	0.00157	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—NPS—migraine	0.000227	0.00157	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR7—migraine	0.000225	0.00156	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR1D—migraine	0.000225	0.00155	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000224	0.00155	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—HTR2C—migraine	0.000223	0.00154	CbGpPWpGaD
Dextroamphetamine—Dizziness—Topiramate—migraine	0.000221	0.00102	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—LRP1—migraine	0.00022	0.00152	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000218	0.00151	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—EDNRA—migraine	0.000217	0.0015	CbGpPWpGaD
Dextroamphetamine—Vomiting—Topiramate—migraine	0.000213	0.000982	CcSEcCtD
Dextroamphetamine—Rash—Topiramate—migraine	0.000211	0.000974	CcSEcCtD
Dextroamphetamine—Dermatitis—Topiramate—migraine	0.000211	0.000973	CcSEcCtD
Dextroamphetamine—Headache—Topiramate—migraine	0.00021	0.000968	CcSEcCtD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR2B—migraine	0.000209	0.00144	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000209	0.00144	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000203	0.00141	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000203	0.00141	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000201	0.00139	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR1D—migraine	0.000199	0.00138	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000199	0.00138	CbGpPWpGaD
Dextroamphetamine—Nausea—Topiramate—migraine	0.000199	0.000918	CcSEcCtD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000194	0.00134	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000194	0.00134	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000189	0.00131	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR2B—migraine	0.000185	0.00128	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000185	0.00128	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000179	0.00124	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000178	0.00123	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—RAMP1—migraine	0.000175	0.00121	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CALCRL—migraine	0.000175	0.00121	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—HTR2A—migraine	0.000173	0.0012	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000172	0.00119	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000172	0.00119	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00017	0.00118	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000169	0.00117	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000169	0.00117	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NOTCH4—migraine	0.000169	0.00117	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000167	0.00116	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000166	0.00115	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR1B—migraine	0.000163	0.00113	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000162	0.00112	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000159	0.0011	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CALCRL—migraine	0.000159	0.0011	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—RAMP1—migraine	0.000159	0.0011	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—HTR2A—migraine	0.000157	0.00109	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR1A—migraine	0.000157	0.00109	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CALCRL—migraine	0.000155	0.00107	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—RAMP1—migraine	0.000155	0.00107	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NPS—migraine	0.000155	0.00107	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TAC1—migraine	0.000155	0.00107	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PGR—migraine	0.000155	0.00107	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—HTR2A—migraine	0.000154	0.00106	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000153	0.00106	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR2C—migraine	0.000152	0.00105	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000151	0.00104	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00015	0.00104	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00015	0.00104	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000148	0.00102	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—EDNRA—migraine	0.000147	0.00102	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000145	0.00101	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—NOTCH3—migraine	0.000144	0.000994	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000144	0.000993	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CALCA—migraine	0.000142	0.000982	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CALCRL—migraine	0.000141	0.000975	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—RAMP1—migraine	0.000141	0.000975	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000138	0.000952	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—HTR2A—migraine	0.000137	0.000946	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR1B—migraine	0.000136	0.000942	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR7—migraine	0.000133	0.000919	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR1A—migraine	0.000131	0.000906	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000129	0.000894	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—TAC1—migraine	0.000129	0.000893	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—NPS—migraine	0.000129	0.000893	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR1D—migraine	0.000127	0.000878	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR2C—migraine	0.000126	0.000875	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—EDNRA—migraine	0.000123	0.000852	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000122	0.000846	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR1B—migraine	0.000121	0.000836	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000119	0.000823	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CALCA—migraine	0.000118	0.00082	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR2B—migraine	0.000118	0.000816	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR1A—migraine	0.000116	0.000805	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR1D—migraine	0.000115	0.000798	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—NPS—migraine	0.000115	0.000793	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—TAC1—migraine	0.000115	0.000793	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TGFBR2—migraine	0.000114	0.000791	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR1D—migraine	0.000113	0.00078	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR2C—migraine	0.000112	0.000778	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR7—migraine	0.000111	0.000767	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—EDNRA—migraine	0.000109	0.000756	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR2B—migraine	0.000107	0.000741	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000106	0.000731	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CALCA—migraine	0.000105	0.000728	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR2B—migraine	0.000105	0.000725	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR1D—migraine	0.000102	0.000708	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000102	0.000705	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR7—migraine	9.84e-05	0.000681	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR2B—migraine	9.52e-05	0.000659	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CALCRL—migraine	9.37e-05	0.000648	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RAMP1—migraine	9.37e-05	0.000648	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—HTR2A—migraine	9.3e-05	0.000644	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	9.05e-05	0.000626	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CALCRL—migraine	8.32e-05	0.000576	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RAMP1—migraine	8.32e-05	0.000576	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ESR1—migraine	8.25e-05	0.000571	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—HTR2A—migraine	7.76e-05	0.000537	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR1B—migraine	7.69e-05	0.000532	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR1A—migraine	7.4e-05	0.000512	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—TAC1—migraine	7.29e-05	0.000504	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—NPS—migraine	7.29e-05	0.000504	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR2C—migraine	7.15e-05	0.000495	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR1B—migraine	6.98e-05	0.000483	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—EDNRA—migraine	6.95e-05	0.000481	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—HTR2A—migraine	6.89e-05	0.000477	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR1B—migraine	6.83e-05	0.000473	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR1D—migraine	6.81e-05	0.000471	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR1A—migraine	6.72e-05	0.000465	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CALCA—migraine	6.69e-05	0.000463	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—NPS—migraine	6.62e-05	0.000458	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—TAC1—migraine	6.62e-05	0.000458	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR1A—migraine	6.57e-05	0.000455	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR2C—migraine	6.49e-05	0.000449	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—NPS—migraine	6.47e-05	0.000448	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—TAC1—migraine	6.47e-05	0.000448	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR2C—migraine	6.35e-05	0.000439	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2B—migraine	6.33e-05	0.000438	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EDNRA—migraine	6.31e-05	0.000437	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR7—migraine	6.26e-05	0.000433	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR1B—migraine	6.2e-05	0.000429	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—EDNRA—migraine	6.18e-05	0.000427	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CALCA—migraine	6.08e-05	0.000421	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR1D—migraine	6.05e-05	0.000418	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR1A—migraine	5.97e-05	0.000413	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CALCA—migraine	5.94e-05	0.000411	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—NPS—migraine	5.88e-05	0.000407	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—TAC1—migraine	5.88e-05	0.000407	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR2C—migraine	5.76e-05	0.000399	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR7—migraine	5.68e-05	0.000393	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2B—migraine	5.62e-05	0.000389	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EDNRA—migraine	5.61e-05	0.000388	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LRP1—migraine	5.57e-05	0.000386	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR7—migraine	5.56e-05	0.000385	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CALCA—migraine	5.4e-05	0.000374	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR7—migraine	5.05e-05	0.000349	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LRP1—migraine	4.95e-05	0.000343	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CACNA1A—migraine	4.57e-05	0.000316	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—HTR2A—migraine	4.38e-05	0.000303	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH4—migraine	4.27e-05	0.000296	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR1B—migraine	4.12e-05	0.000285	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HTR2A—migraine	3.98e-05	0.000276	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR1A—migraine	3.97e-05	0.000275	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NPS—migraine	3.91e-05	0.000271	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TAC1—migraine	3.91e-05	0.000271	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PGR—migraine	3.91e-05	0.000271	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—HTR2A—migraine	3.89e-05	0.00027	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2C—migraine	3.83e-05	0.000265	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH4—migraine	3.8e-05	0.000263	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EDNRA—migraine	3.73e-05	0.000258	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR1B—migraine	3.66e-05	0.000254	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH3—migraine	3.63e-05	0.000252	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CALCA—migraine	3.59e-05	0.000248	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HTR2A—migraine	3.54e-05	0.000245	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR1A—migraine	3.53e-05	0.000244	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NPS—migraine	3.47e-05	0.00024	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PGR—migraine	3.47e-05	0.00024	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TAC1—migraine	3.47e-05	0.00024	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2C—migraine	3.41e-05	0.000236	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR7—migraine	3.36e-05	0.000232	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EDNRA—migraine	3.31e-05	0.000229	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH3—migraine	3.23e-05	0.000223	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CALCA—migraine	3.19e-05	0.000221	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR7—migraine	2.98e-05	0.000206	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFBR2—migraine	2.89e-05	0.0002	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFBR2—migraine	2.57e-05	0.000178	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2A—migraine	2.35e-05	0.000163	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2A—migraine	2.09e-05	0.000145	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ESR1—migraine	2.09e-05	0.000144	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ESR1—migraine	1.85e-05	0.000128	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—migraine	1.51e-05	0.000105	CbGpPWpGaD
